Article
Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data.
Translational psychiatry - 12 Feb 2024
Thamilselvan Megana, Mather Cheryl, Wang Yabing, Foo Jerome C, Aitchison Katherine J
Abstract excerpt
Pharmacogenomics aims to use the genetic information of an individual to personalize drug prescribing. There is evidence that pharmacogenomic testing before prescription may prevent adverse drug reactions, increase efficacy, and reduce cost of treatment. CYP2D6 is a key pharmacogene of relevance to multiple therapeutic areas. Indeed, there are prescribing guidelines available for medications based on CYP2D6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
